Imcyse: Imcyse concludes enrolment in Type 1 diabetes therapy trial
Topline results from the Phase II clinical trial are expected in the first quarter of next year. The post Imcyse concludes enrolment in Type 1 diabetes therapy trial appeared first on Clinical Trials Arena.
Read full article »
Imcyse is a biopharmaceutical company that develops and commercializes immunotherapies for the treatment of chronic autoimmune diseases.
Read more